about
Inflammation Models of Depression in Rodents: Relevance to Psychotropic Drug DiscoveryPharmacological approaches to the challenge of treatment-resistant depressionPolyunsaturated fatty acids moderate the effect of poor sleep on depression riskInflammation and Immune Regulation as Potential Drug Targets in Antidepressant Treatment.Neuroimmune Interface in the Comorbidity between Alcohol Use Disorder and Major Depression.Temporal Association of Certain Neuropsychiatric Disorders Following Vaccination of Children and Adolescents: A Pilot Case-Control Study.Sleep and inflammatory markers in different psychiatric disorders.Diagnostic and therapeutic potentials of exosomes in CNS diseases.Chronic kidney disease in lithium-treated older adults: a review of epidemiology, mechanisms, and implications for the treatment of late-life mood disorders.Animal inflammation-based models of depression and their application to drug discovery.Sleep disturbance and kynurenine metabolism in depression.Postdialysis Fatigue: A Frequent and Debilitating Symptom.Acute ketamine administration corrects abnormal inflammatory bone markers in major depressive disorder.Molecular hydrogen increases resilience to stress in mice.Weight Loss, Diabetes, Fatigue, and Depression Preceding Pancreatic Cancer.Plasma complement component 4 increases in patients with major depressive disorder.Peripheral immune factors are elevated in women with current or recent alcohol dependence and associated with altered mood and memory.Translocator protein ligand, YL-IPA08, attenuates lipopolysaccharide-induced depression-like behavior by promoting neural regeneration
P2860
Q26749497-386127A0-E113-495F-A6F1-1BD56E553C30Q26798241-05DE02FB-AD65-4E8A-A273-2BDA23BD05B7Q36642579-184EB929-EE1B-48B0-B939-F767A2FE7BA3Q37310533-11BB0522-A46F-4915-A8E6-194E89A03790Q37532906-8503AF59-7A87-4BEC-B336-486604956661Q37592975-331D4BC2-D243-46DE-9763-C9EBD3BF69F1Q37614680-D5D0E041-7534-42AD-A388-3FCD262FD908Q38259010-4584CA5B-40DA-48A7-95C3-EA7BBCF5347DQ38292314-68D900D0-C830-4CF5-B623-9E761302F8D7Q38620528-3E5A90E9-0F2A-4F7A-8966-096DE21AF295Q38676972-1C93202E-14D4-43BA-AF7B-90B6CA293C7DQ38710377-AD393559-7B7E-4C51-9D46-9BE3B5903CAAQ38758007-95D9672B-3C8F-49D3-9B00-6CB39D14261AQ39311969-1664D96E-6AD1-498F-B108-0A9E046C989BQ41030230-57DC82B9-D2DD-4F61-83AF-EDCF58535CCFQ47142811-607E2090-E431-40EC-891D-0FA9C1464569Q47718372-580BBB7E-E9B0-4776-BD16-905885889D0EQ58702659-EADA8B6E-D967-432A-A058-EBB651774E03
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Inflammatory cytokine-associated depression
@ast
Inflammatory cytokine-associated depression
@en
Inflammatory cytokine-associated depression
@nl
type
label
Inflammatory cytokine-associated depression
@ast
Inflammatory cytokine-associated depression
@en
Inflammatory cytokine-associated depression
@nl
prefLabel
Inflammatory cytokine-associated depression
@ast
Inflammatory cytokine-associated depression
@en
Inflammatory cytokine-associated depression
@nl
P2860
P1433
P1476
Inflammatory cytokine-associated depression
@en
P2093
Francis E Lotrich
P2860
P304
P356
10.1016/J.BRAINRES.2014.06.032
P407
P577
2014-07-05T00:00:00Z